How many ml is each Wegovy dose, and does it change as the dose increases?

Why every Wegovy pen delivers the same volume, whatever the number on the label

The engineering logic here is straightforward. Novo Nordisk manufactures Wegovy pens so that a single actuation always expels 1.34 ml. What changes between a 0.25 mg starter pen and a 2.4 mg maintenance pen is how much semaglutide is dissolved in that fixed volume. At 0.25 mg the concentration is approximately 0.187 mg/ml; at 2.4 mg it reaches roughly 1.79 mg/ml. The pen you hold in your hand looks largely the same; the medicine inside is more concentrated.

This design is deliberate. A fixed-volume device means fewer variables for the person injecting: there is no dial to set, no volume to calculate, no mental arithmetic before each dose. The Wegovy SmPC on the eMC sets out the concentration for each strength alongside storage conditions and the full instructions for use, and the Patient Information Leaflet in the box covers the injection technique step by step. If anything about the injection process feels unclear, that leaflet is the right place to start before contacting a prescriber.

One practical consequence worth knowing: because the volume is identical at every strength, injecting the starter dose and injecting the maintenance dose feel physically the same. The pen is the same size, the press of the button delivers the same amount of liquid, and the injection takes the same few seconds. For people anxious about needles, that consistency can be reassuring.

The titration schedule: what the ml figure looks like at each step

Wegovy's licensed titration moves in roughly four-week steps, each step raising the amount of semaglutide per injection while keeping the volume at 1.34 ml. The schedule runs: 0.25 mg (four weeks), then 0.5 mg (four weeks), then 1.0 mg (four weeks), then 1.7 mg (four weeks), and finally the 2.4 mg maintenance dose. The MHRA-approved 7.2 mg dose (confirmed in January 2026 and available as a dedicated single-dose pen from April 2026) follows the same principle of a fixed delivered volume per injection.

For the 2.4 mg strength specifically, there is a closer look at the 2.4 mg pen's volume and concentration that may help if you are approaching maintenance. Similarly, if you want to understand the earliest step, the 0.25 mg volume explained covers the starter pen in the same detail.

Knowing where you are in the schedule matters because each pen is labelled by dose strength, not by volume. If your pen says 0.5 mg, it will still deliver 1.34 ml, the same as the 0.25 mg pen that came before it. The number on the label tells you the therapeutic content, not the syringe volume.

What arrives and how to read the pen you receive

When your Wegovy pen arrives (tracked by DPD, in plain unbranded packaging) there will be a dose label on the carton stating the strength, a batch number, and an expiry date. The pen itself has a dose window and, depending on the presentation, either individual needle caps to change each week or a built-in needle mechanism. For the standard multi-dose pen, each pen holds four weekly doses, each of 1.34 ml, used over the course of one month.

There is no volume marking on the pen's exterior in the way a traditional syringe has graduated lines. You do not measure the liquid before injecting. The pen mechanism is pre-set by the manufacturer. This is by design: a pre-filled auto-injector removes measurement error entirely. A question our prescribers hear regularly is whether a pen that looks less than full might be faulty, the answer is almost always that pens are filled to deliver four precise doses, and the visible liquid level at the start will reflect that fill rather than a full syringe.

For a fuller picture of the pen's total contents, the total semaglutide per pen by strength breaks this down dose by dose.

Volume, dose and the prescriber's role in adjusting both

One question that sometimes follows from understanding the fixed volume is whether you could change your dose by injecting only part of the pen's delivery. The answer is no, and attempting to do so would be both unsafe and ineffective. The pen is engineered for a single, complete actuation per weekly dose. Partial injections are not a sanctioned method of dose adjustment under any clinical guidance, and the SmPC does not describe any such approach.

Dose decisions belong to your prescriber. If side effects at a given strength are difficult, if titration needs to pause, or if there is a clinical reason to step down, those are conversations to have with the clinician who issued your prescription. The full Wegovy dose guide covers the schedule and what to expect at each step, while the main Wegovy treatment overview explains eligibility and how the medicine fits into a broader weight management plan.

If you are considering starting treatment and want to understand the costs involved before committing, the Wegovy pricing guide explains the UK private market honestly, including what legitimate services include in a quoted price. For anyone ready to discuss their own suitability, starting a free consultation connects you with a GPhC-registered prescriber who can review your history the same day.